Literature DB >> 26355625

Emerging Therapies for Androgenetic Alopecia.

Terrence Keaney.   

Abstract

Androgenetic alopecia is the progressive miniaturization of the scalp's terminal follicles in aging men. Over 40% of Caucasian men develop hair loss by the age of 40. Despite its prevalence, there are only two FDA approved medications to treat the condition. Recognizing the unmet need, new medical, procedural, and surgical treatments are being adopted to combat progressive hair loss. This review examines emerging hair loss treatments including medical therapies that the target prostaglandins, low level light therapy, platelet rich plasma injections, and robotic hair transplantation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26355625

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  1 in total

1.  Blue light-emitting diodes in hair regrowth: the first prospective study.

Authors:  G Lodi; M Sannino; G Cannarozzo; A Giudice; E Del Duca; F Tamburi; Luigi Bennardo; S P Nisticò
Journal:  Lasers Med Sci       Date:  2021-06-08       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.